Back
Published on 16/05/2022
Extens, the leading French investment fund specifically dedicated to healthcare software and data, has appointed Charles Bourgain as Investment Director. This addition is part of the consolidation of the company's investment team, which is currently finalizing the raising of its Extens III fund.
With six years of experience in private equity, focusing on investment operations in France and Europe, Charles will contribute to the deployment of the Extens III fund and the preparation for future fundraising.
Charles Bourgain (ENSEEIHT, ESSEC Business School) began his career with the teams at Turenne Groupe as an analyst before being promoted to associate. He then joined Essling Capital, where he actively participated in deploying the Essling Expansion fund, making investments in several software publishers, including inWebo and Evolucare. With an engineering background, Charles has developed a particular interest in this dynamic and ever-evolving market. Very involved in the private equity ecosystem, he is a member of the Board of Directors for under-35s at France Invest and a member of France Invest Avenir, where he previously served as president and which aims to support the new generation of private equity.
Charles Bourgain states: “I was drawn to Extens's entrepreneurial project, its investment thesis, and its commitment to working alongside the leaders of portfolio companies. The software market offers numerous growth opportunities, and healthcare software serves as a vehicle for creating value for our society and our healthcare system. I look forward to contributing to Extens's project and closely supporting the leaders of promising French SMEs, helping them take their development to the next level, and thus participating in the evolution of our healthcare system.”
Indeed, beyond financial performance, Extens is committed to transforming healthcare systems and contributing to the emergence of future solutions, all while maintaining a focus on improving care, enhancing the efficiency of the healthcare system, and optimizing medical costs.
The arrival of Charles complements the existing team alongside Arnaud Houette and Quentin Jacomet. Arnaud Houette and Quentin Jacomet, Managing Partners, comment: “We are delighted to welcome Charles to our team. This strengthening will enable us to accelerate the deployment of our funds and provide even more support and assistance to management teams.”